SCHEMBL6206663

SCHEMBL6206663

CC(C)(C)OC(=O)NCCCC(=O)c1nc2ccccc2o1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.53
CES1 P23141 2/20 0.53
DAGLA Q9Y4D2 2/20 0.53
BCHE P06276 1/20 0.49
BRD4 O60885 3/20 0.44
NPSR1 Q6W5P4 1/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
HIF1A Q16665 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
CYP3A4 P08684 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24934423 0.97 FAAH (0.55) FAAHCES1DAGLABCHEBRD4
SCHEMBL6206334 0.79 MEN1 (0.46) BCHEBRD4NPSR1MAPTGAA
SCHEMBL27805184 0.78 DAGLA (0.67) FAAHCES1DAGLA
SCHEMBL29025518 0.78 MEN1 (0.45) BCHEBRD4NPSR1MAPTGAA
SCHEMBL1980682 0.78 BCHE (0.58) BCHEBRD4MAPTKDM4EALDH1A1
SCHEMBL30831344 0.77 HDAC6 (0.55) BCHENPSR1MAPTALDH1A1GAA
SCHEMBL7049753 0.75 BCHE (0.41) BCHEBRD4MAPTKDM4EGAA
SCHEMBL5422852 0.75 CTSS (0.52) CYP3A4
SCHEMBL1929771 0.75 SIGMAR1 (0.52) BCHEMAPTGAASIGMAR1CYP3A4
SCHEMBL28665621 0.75 XDH (0.52) FAAHCES1DAGLAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515726-A1 MORPHOLINE AND TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2005-03-23 EP disclosed
WO-2004002491-A1 MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2004-01-08 WO disclosed